Nuveen LLC Acquires New Stake in Teleflex Incorporated $TFX

Key Points

• Nuveen LLC has acquired 115,163 shares of Teleflex Incorporated, valued at approximately $15.9 million, increasing its ownership to about 0.26% of the company.
• Insider transactions included CEO Liam Kelly purchasing 1,500 shares for around $172,605, while Director Gretchen R. Haggerty bought 500 shares valued at $57,375.
• Teleflex's most recent quarterly earnings showed an EPS of $3.73, surpassing estimates, with the company also declaring a quarterly dividend of $0.34 per share.

Nuveen LLC bought a new position in Teleflex Incorporated (NYSE:TFX - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 115,163 shares of the medical technology company's stock, valued at approximately $15,914,000. Nuveen LLC owned about 0.26% of Teleflex as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in TFX. MassMutual Private Wealth & Trust FSB increased its stake in Teleflex by 103.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock worth $27,000 after acquiring an additional 100 shares during the last quarter. Banque Cantonale Vaudoise bought a new position in Teleflex in the 1st quarter worth about $27,000. Costello Asset Management INC purchased a new position in shares of Teleflex in the 1st quarter worth about $28,000. Whipplewood Advisors LLC boosted its holdings in shares of Teleflex by 7,700.0% in the 1st quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company's stock worth $32,000 after purchasing an additional 231 shares in the last quarter. Finally, Allworth Financial LP boosted its holdings in shares of Teleflex by 504.8% in the 1st quarter. Allworth Financial LP now owns 254 shares of the medical technology company's stock worth $34,000 after purchasing an additional 212 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Teleflex

In other Teleflex news, Director Andrew A. Krakauer purchased 1,000 shares of the stock in a transaction on Tuesday, August 5th. The stock was acquired at an average price of $115.25 per share, with a total value of $115,250.00. Following the transaction, the director directly owned 7,192 shares of the company's stock, valued at approximately $828,878. This trade represents a 16.15% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Stuart A. Randle bought 1,000 shares of the firm's stock in a transaction dated Tuesday, August 5th. The stock was purchased at an average cost of $115.86 per share, with a total value of $115,860.00. Following the transaction, the director directly owned 7,547 shares in the company, valued at approximately $874,395.42. This represents a 15.27% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 5,500 shares of company stock worth $633,590 over the last three months. 1.40% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research firms have recently issued reports on TFX. Truist Financial cut their price objective on Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a report on Monday, May 5th. Morgan Stanley cut their price objective on Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a report on Monday, May 5th. Wells Fargo & Company cut their price objective on Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a report on Friday, August 1st. Royal Bank Of Canada upped their price objective on Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a report on Friday, August 1st. Finally, Wall Street Zen upgraded Teleflex from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 2nd. One analyst has rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $141.57.

Teleflex Trading Down 0.2%

TFX traded down $0.26 during midday trading on Tuesday, reaching $127.29. 477,949 shares of the company's stock traded hands, compared to its average volume of 572,465. The firm has a fifty day moving average of $118.48 and a two-hundred day moving average of $130.01. The stock has a market capitalization of $5.63 billion, a price-to-earnings ratio of 29.95, a P/E/G ratio of 1.78 and a beta of 1.08. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.41 and a quick ratio of 1.44. Teleflex Incorporated has a 52 week low of $108.90 and a 52 week high of $249.90.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, beating analysts' consensus estimates of $3.36 by $0.37. The business had revenue of $780.90 million during the quarter, compared to analyst estimates of $771.53 million. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.Teleflex's quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.42 EPS. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. On average, equities analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Friday, August 15th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. Teleflex's dividend payout ratio is presently 32.00%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.